PMV Pharmaceuticals, Inc. — Investor Relations & Filings
Filings indexed
357
across all filing types
Latest filing
2026-05-12
Interim / Quarterly Rep…
Country
US
United States of America
Listing
US
PMVP
PMV Pharmaceuticals, Inc. is a clinical-stage precision oncology company focused on the discovery and development of small molecule, tumor-agnostic therapies. The company's research centers on the p53 tumor suppressor protein, which is mutated in approximately half of all human cancers. PMV Pharmaceuticals develops first-in-class drug candidates, referred to as p53 regulators, designed to selectively target these mutations. The company's therapeutic approach aims to structurally correct the mutated p53 protein, thereby restoring its normal, wild-type tumor-suppressing function to treat various forms of cancer.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q - PMV Pharmaceuticals, Inc. (0001699382) (Filer) | 2026-05-12 | English | |
| 8-K - PMV Pharmaceuticals, Inc. (0001699382) (Filer) | 2026-05-12 | English | |
| ARS - PMV Pharmaceuticals, Inc. (0001699382) (Filer) | 2026-04-22 | English | |
| DEF 14A - PMV Pharmaceuticals, Inc. (0001699382) (Filer) | 2026-04-22 | English | |
| SCHEDULE 13G/A Filing | 2026-02-17 | English | |
| SCHEDULE 13G/A Filing | 2026-02-09 | English |
Browse filings by year
8 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
6 filings
| |||||
| 45252546 | 10-Q - PMV Pharmaceuticals, Inc. (0001699382) (Filer) | 2026-05-12 | English | ||
| 45252460 | 8-K - PMV Pharmaceuticals, Inc. (0001699382) (Filer) | 2026-05-12 | English | ||
| 35240446 | ARS - PMV Pharmaceuticals, Inc. (0001699382) (Filer) | 2026-04-22 | English | ||
| 35239141 | DEF 14A - PMV Pharmaceuticals, Inc. (0001699382) (Filer) | 2026-04-22 | English | ||
| 31360410 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 31360485 | SCHEDULE 13G/A Filing | 2026-02-09 | English | ||
|
2025
9 filings
| |||||
| 13014892 | 10-Q | 2025-11-12 | English | ||
| 13014894 | 8-K | 2025-11-12 | English | ||
| 13014895 | Major Shareholding Notification 2025 | 2025-11-12 | English | ||
| 13014896 | Director's Dealing 2025 | 2025-10-29 | English | ||
| 13014897 | Director's Dealing 2025 | 2025-10-27 | English | ||
| 13014898 | Major Shareholding Notification 2025 | 2025-10-27 | English | ||
| 13014900 | Regulatory Filings 2025 | 2025-10-23 | English | ||
| 13014899 | Major Shareholding Notification 2025 | 2025-09-23 | English | ||
| 13014901 | Director's Dealing 2025 | 2025-09-12 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Adlai Nortye Ltd.
A clinical-stage biopharma firm developing cancer immunothe…
|
ANL | KY | Manufacturing |
|
ADLINE CHEM LAB LIMITED
Produces APIs, chemical intermediates, and specialty chemic…
|
524604 | IN | Manufacturing |
|
ADMA BIOLOGICS, INC.
Biopharmaceutical company that develops and manufactures pl…
|
ADMA | US | Manufacturing |
|
Advectus Life Sciences Inc.
Advances drug delivery systems using proprietary nanopartic…
|
AVXSF | CA | Manufacturing |
|
Adverum Biotechnologies, Inc.
A clinical-stage company developing gene therapies for ocul…
|
ADVM | US | Manufacturing |
|
Advicenne
A specialty pharmaceutical company developing treatments fo…
|
ALDVI | FR | Manufacturing |
|
AegirBio AB
A diagnostics company specializing in therapeutic drug moni…
|
AEGIR | SE | Manufacturing |
|
Aelis Farma
Biopharmaceutical company developing CB1 receptor inhibitor…
|
AELIS | FR | Manufacturing |
|
AEON Biopharma, Inc.
Clinical-stage company developing therapeutic applications …
|
AEON | US | Manufacturing |
|
Aequus Pharmaceuticals Inc.
Developing and commercializing specialty pharmaceutical pro…
|
AQS | CA | Manufacturing |
PMV Pharmaceuticals, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34350/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34350 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34350 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34350 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34350}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for PMV Pharmaceuticals, Inc. (id: 34350)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.